JAK3 and primary cutaneous T-cell non-Hodgkin lymphoma: Nuclear localization of JAK3 has recently been observed in HIV-infected CD4+ T cells [32] which prompted us to hypothesize that malignant CD4+ T cells from CTCL patients may also display ectopic expression and function of JAK3.